Arizona Bioscience News: HonorHealth Research Institute; CAMI construction halts; XLR8 PBC

March 21, 2025

By Jessica Vaile

HonorHealth institute opens Bioscience Core lab / Phoenix Business Journal

Scottsdale-based HonorHealth Research Institute opened its $7 million, 2,500-square-foot Center for Translational Science laboratory on the Phoenix Bioscience Core campus in downtown Phoenix within the 850 PBC building developed by Wexford Science + Technology.


University of Arizona stops work on $300M Phoenix biomedical hub amid federal funding uncertainty / Phoenix Business Journal

Construction of the $300 million University of Arizona’s Center for Advanced Molecular and Immunological Therapies, or CAMI, in downtown Phoenix is on hold because of federal funding uncertainty.


New UA study deepens link between aging songbirds and Alzheimer’s in humans / KJZZ

Researchers at the University of Arizona have published a study highlighting how vocal changes in the zebra finch songbirds may help in understanding neurodegenerative disorders in people. Read more: University of Arizona researchers gets $1.2M to explore neighborhood impact on cancer risk


XLR8 PBC announces inaugural cohort of startups / Phoenix Business Journal (AZ Inno)

An inaugural cohort of four health-tech startups, including Arizona-based The Patient Company, will participate in XLR8 PBC—a new program affiliated with the Phoenix Bioscience Core that offers tailored support, networking opportunities, and collaboration within Arizona’s thriving bioscience ecosystem.


10 companies, 5 nations, 1 accelerator: A wide range of innovative health care solutions / Phoenix Business Journal (AZ Inno)

The 10 companies participating in the two-week 2025 Mayo Clinic and ASU MedTech Accelerator—the first cohort to have representation from life science companies­—include Arizona startups The Pause.ai and WellBeings.


Scottsdale neuroscience company among two Flinn Foundation entrepreneurship winners / Phoenix Business Journal

Scottsdale-based brain treatment firm Anuncia Medical and Oro Valley’s Macula Vision Systems were selected as funding recipients out of a group of 10 Flinn Foundation Bioscience Entrepreneurship Program participants. The remaining participants include Aces Diagnostics, Aspiro Therapeutics, Harmonic Discovery, Hypersound Medical, ImmunoShield Therapeutics, King Therapeutics, MindFit, and Paxauris.


Flagstaff researchers continuing to study COVID five years after the start of the pandemic / Arizona Daily Sun

COVID continues to be studied in Flagstaff, from TGen North conducting wastewater testing and studying it in wildlife to understand how it has spread through the environment, to Northern Arizona University researchers using medical anthropology to study people’s reactions to the disease.


Upcoming Events:

April 22: AZBioPEERS: Maximizing Your Investment in Industry & Medical Conferences

April 23: The Latest in Arizona Biosciences

May 5-9: Phoenix Research Week

May 14-16: 48th annual Barrow Neuroscience Symposium

March 25: TechFusion: AI, IT, and Computer Science Conference

Check out our new Bio Blog for the latest news about Arizona’s Bioscience Roadmap.